Impaired skeletal muscle substrate oxidation in glucose-intolerant men improves after weight loss

Obesity

Volumn 16, Issue 5, 2008, Pages 1025-1032

  Corpeleijn, Eva ^a   Mensink, Marco ^a   Kooi, Marianne E ^b   Roekaerts, Paul M H J ^b   Saris, Wim H M ^a   Blaak, Ellen E ^a  

^a MAASTRICHT UNIVERSITY   (Netherlands)

^b MAASTRICHT UNIVERSITY   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

FATTY ACID; TRIACYLGLYCEROL;

ARTICLE; CARBOHYDRATE METABOLISM; CASE CONTROL STUDY; DIET RESTRICTION; EATING; FOREARM; GLUCOSE INTOLERANCE; HUMAN; IMPAIRED GLUCOSE TOLERANCE; MALE; METABOLISM; MIDDLE AGED; OBESITY; OXIDATION REDUCTION REACTION; PATHOPHYSIOLOGY; PHYSIOLOGY; POSTPRANDIAL STATE; SKELETAL MUSCLE; WEIGHT REDUCTION;

CARBOHYDRATE METABOLISM; CASE-CONTROL STUDIES; EATING; FASTING; FATTY ACIDS; FOREARM; GLUCOSE INTOLERANCE; HUMANS; MALE; MIDDLE AGED; MUSCLE, SKELETAL; OBESITY; OXIDATION-REDUCTION; POSTPRANDIAL PERIOD; PREDIABETIC STATE; TRIGLYCERIDES; WEIGHT LOSS;

EID: 42949109650     PISSN: 19307381     EISSN: 1930739X     Source Type: Journal    
DOI: 10.1038/oby.2008.24     Document Type: Article

References (42)

1. Krssak M, Falk Petersen K, Dresner A, et al. Intramyocellular lipid concentrations are correlated with insulin sensitivity in humans: A 1h nmr spectroscopy study. Diabetologia 1999;42:113-116.
2. Levin K, Daa Schroeder H, Alford FP, Beck-Nielsen H. Morphometric documentation of abnormal intramyocellular fat storage and reduced glycogen in obese patients with type ii diabetes. Diabetologia 2001;44:824-833.
3. Ravussin E, Smith SR. Increased fat intake, impaired fat oxidation, and failure of fat cell proliferation result in ectopic fat storage, insulin resistance, and type 2 diabetes mellitus. Ann NY Acad Sci 2002;967:363-378.
4. Kriketos AD, Furler SM, Gan SK et al. Multiple indexes of lipid availability are independently related to whole body insulin action in healthy humans. J Clin Endocrinol Metab 2003;88:793-798.
5. Blaak EE. Basic disturbances in skeletal muscle fatty acid metabolism in obesity and type 2 diabetes mellitus. Proc Nutr Soc 2004;63:323-330.
6. Blaak EE, van Aggel-Leijssen DP, Wagenmakers AJ, Saris WH, van Baak MA. Impaired oxidation of plasma-derived fatty acids in type 2 diabetic subjects during moderate-intensity exercise. Diabetes 2000;49:2102-2107.
7. Blaak EE, Wagenmakers AJ, Glatz JF et al. Plasma FFA utilization and fatty acid-binding protein content are diminished in type 2 diabetic muscle. Am J Physiol Endocrinol Metab 2000;279:E146-E154.
8. Kelley DE, Simoneau JA. Impaired free fatty acid utilization by skeletal muscle in non-insulin-dependent diabetes mellitus. J Clin Invest 1994;94:2349-2356.
9. Kelley DE, Goodpaster B, Wing RR, Simoneau JA. Skeletal muscle fatty acid metabolism in association with insulin resistance, obesity, and weight loss. Am J Physiol 1999;277:E1130-E1141.
10. Petersen KF, Dufour S, Befroy D, Garcia R, Shulman GI. Impaired mitochondrial activity in the insulin-resistant offspring of patients with type 2 diabetes. N Engl J Med 2004;350:664-671.
11. Schmitz-Peiffer C. Signalling aspects of insulin resistance in skeletal muscle: mechanisms induced by lipid oversupply. Cell Signal 2000;12:583-594.
12. Itani SI, Ruderman NB, Schmieder F, Boden G. Lipid-induced insulin resistance in human muscle is associated with changes in diacylglycerol, protein kinase c, and ikappab-alpha. Diabetes 2002;51:2005-2011.
13. Boden G, Laakso M. Lipids and glucose in type 2 diabetes: what is the cause and effect? Diabetes Care 2004;27:2253-2259.
14. Zurlo F, Lillioja S, Esposito-Del Puente A et al. Low ratio of fat to carbohydrate oxidation as predictor of weight gain: Study of 24-h rq. Am J Physiol 1990;259:E650-E657.
15. Seidell JC, Muller DC, Sorkin JD, Andres R. Fasting respiratory exchange ratio and resting metabolic rate as predictors of weight gain: the Baltimore longitudinal study on aging. Int J Obes Relat Metab Disord 1992;16:667-674.
16. Morino K, Petersen KF, Shulman GI. Molecular mechanisms of insulin resistance in humans and their potential links with mitochondrial dysfunction. Diabetes 2006;55(Suppl 2):S9-S15.
17. Turpeinen AK, Takala TO, Nuutila P et al. Impaired free fatty acid uptake in skeletal muscle but not in myocardium in patients with impaired glucose tolerance: studies with pet and 14(r,s)-[18f]fluoro-6-thia-heptadecanoic acid. Diabetes 1999;48:1245-1250.
18. WHO. Definition, diagnosis and classification of diabetes mellitus and its complications. Report of a who consultation part 1: diagnosis and classification of diabetes mellitus. World Health Organ Tech Rep Ser 1999:1-59.
19. Siri W. The gross composition of the body. Adv Bio Med Physiol 1956;4:239-280.
20. Mensink M, Corpeleijn E, Feskens EJ et al. Study on lifestyle-intervention and impaired glucose tolerance maastricht (slim): design and screening results. Diabetes Res Clin Pract 2003;61:49-58.
21. Bergstrom J, Hermansen L, Hultman E, Saltin B. Diet, muscle glycogen and physical performance. Acta Physiol Scand 1967;71:140-150.
22. Schrauwen-Hinderling VB, van Loon LJ, Koopman R et al. Intramyocellular lipid content is increased after exercise in nonexercising human skeletal muscle. J Appl Physiol 2003;95:2328-2332.
23. Frayn KN, Lund P, Walker M. Interpretation of oxygen and carbon dioxide exchange across tissue beds in vivo. Clin Sci (Colch) 1993;85:373-384.
24. Steele R. Influences of glucose loading and of injected insulin on hepatic glucose output. Ann NY Acad Sci 1959;82:420-430.
25. Mensink M, Blaak EE, van Baak MA, Wagenmakers AJ, Saris WH. Plasma free fatty acid uptake and oxidation are already diminished in subjects at high risk for developing type 2 diabetes. Diabetes 2001;50:2548-2554.
26. Shepherd D, Garland PB. Citrate synthase from rat liver. Methods Enzymol 1969;13:11-16.
27. Bergmeyer HU, Gawehn K, Grassl M. 3-Hydroxyacyl-CoA dehydrogenase. In: Bergmeyer HU (ed). Methods of Enzymatic Analysis, Vol 1. Verlag Chemie: Weinheim, 1974, p 474.
28. Kelley DE. Skeletal muscle fat oxidation: timing and flexibility are everything. J Clin Invest 2005;115:1699-1702.
29. Ukropcova B, McNeil M, Sereda O et al. Dynamic changes in fat oxidation in human primary myocytes mirror metabolic characteristics of the donor. J Clin Invest 2005;115:1934-1941.
30. Goodpaster BH, Katsiaras A, Kelley DE. Enhanced fat oxidation through physical activity is associated with improvements in insulin sensitivity in obesity. Diabetes 2003;52:2191-2197.
31. Gaster M, Rustan AC, Aas V, Beck-Nielsen H. Reduced lipid oxidation in skeletal muscle from type 2 diabetic subjects may be of genetic origin: evidence from cultured myotubes. Diabetes 2004;53:542-548.
32. Blaak EE, Wolffenbuttel BH, Saris WH, Pelsers MM, Wagenmakers AJ. Weight reduction and the impaired plasma-derived free fatty acid oxidation in type 2 diabetic subjects. J Clin Endocrinol Metab 2001;86:1638-1644.
33. Luiken JJ, Arumugam Y, Dyck DJ et al. Increased rates of fatty acid uptake and plasmalemmal fatty acid transporters in obese zucker rats. J Biol Chem 2001;276:40567-40573.
34. Bonen A, Parolin ML, Steinberg GR et al. Triacylglycerol accumulation in human obesity and type 2 diabetes is associated with increased rates of skeletal muscle fatty acid transport and increased sarcolemmal fat/cd36. FASEB J 2004;18:1144-1146.
35. Ravikumar B, Carey PE, Snaar JE et al. Real-time assessment of postprandial fat storage in liver and skeletal muscle in health and type 2 diabetes. Am J Physiol Endocrinol Metab 2005;288:E789-E797.
36. Guo Z, Zhou L, Jensen MD. Acute hyperinsulinemia inhibits intramyocellular triglyceride synthesis in high-fat-fed obese rats. J Lipid Res 2006;47:2640-2646.
37. Felber JP, Ferrannini E, Golay A et al. Role of lipid oxidation in pathogenesis of insulin resistance of obesity and type ii diabetes. Diabetes 1987;36:1341-1350.
38. Goodpaster BH, Theriault R, Watkins SC, Kelley DE. Intramuscular lipid content is increased in obesity and decreased by weight loss. Metabolism 2000;49:467-472.
39. Gray RE, Tanner CJ, Pories WJ, MacDonald KG, Houmard JA. Effect of weight loss on muscle lipid content in morbidly obese subjects. Am J Physiol Endocrinol Metab 2003;284:E726-E732.
40. Malenfant P, Tremblay A, Doucet E et al. Elevated intramyocellular lipid concentration in obese subjects is not reduced after diet and exercise training. Am J Physiol Endocrinol Metab 2001;280:E632-E639.
41. Hood DA, Zak R, Pette D. Chronic stimulation of rat skeletal muscle induces coordinate increases in mitochondrial and nuclear mrnas of cytochrome-c-oxidase subunits. Eur J Biochem 1989;179:275-280.
42. Williams RS. Mitochondrial gene expression in mammalian striated muscle. Evidence that variation in gene dosage is the major regulatory event. J Biol Chem 1986;261:12390-12394.